U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170644) titled 'A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)' on July 31.
Brief Summary: This study is being conducted to characterize the efficacy and safety of nirogacestat in Japanese adults with progressing desmoid tumors/aggressive fibromatosis.
Study Start Date: Aug. 08
Study Type: INTERVENTIONAL
Condition:
Desmoid Tumor
Aggressive Fibromatosis
Intervention:
DRUG: Nirogacestat oral tablet
Nirogacestat tablet
Recruitment Status: RECRUITING
Sponsor: SpringWorks Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....